NCT01916109 Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer Status TERMINATED Phase PHASE2
NCT01912625 Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery Status TERMINATED Phase PHASE1
NCT01911598 A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) Status COMPLETED Phase PHASE1
NCT01898494 Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01887340 Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma Status RECRUITING Phase PHASE2
NCT01881230 Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) Status COMPLETED Phase PHASE2/PHASE3
NCT01868022 Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling Status COMPLETED Phase PHASE1
NCT01862328 Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors Status COMPLETED Phase PHASE1
NCT01847677 Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin Status TERMINATED Phase PHASE2
NCT01847326 Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT01843829 A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer Status UNKNOWN Phase PHASE2
NCT01837862 A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT01837251 Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer Status COMPLETED Phase PHASE3
NCT01836679 Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01836575 Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2 Status COMPLETED Phase PHASE3
NCT01836341 Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation Status WITHDRAWN Phase PHASE1
NCT01836029 Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT01828736 Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma Status COMPLETED Phase PHASE2
NCT01828099 LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT01827384 MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene Variations Status COMPLETED Phase PHASE2